Fri 26 Jul 2019
PHARMACEUTICAL production demands complex Mechanical and Electrical designs to ensure Medical and Health products Regulatory Agency (MHRA) approval yet at the same time deliver efficient, sustainable and affordable manufacture.
Glaxo Smith Kline has been investing heavily in updating its plant for both Research and Development and production at its Barnard Castle site and Service Design Partnership have been a trusted provider.
Gradually the site is taking shape with buildings opening and re-opening.
Below are some of the first to open including the main façade which serves as a showcase for the company as it looks to deliver on its future business objectives.